- Global Pharma News & Resources

TraceLink Announces Final Speaker Line Up for FutureLink Chicago, Including Industry Leaders from Abbott, Biogen, Pfizer, and McKesson

TraceLink Announces Final Speaker Line Up for FutureLink Chicago, Including Industry Leaders from Abbott, Biogen, Pfizer, and McKesson

PR Newswire

NORTH READING, Mass., Oct. 23, 2018

NORTH READING, Mass., Oct. 23, 2018 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced the final line-up of industry speakers confirmed for FutureLink Chicago, taking place November 5 -7, 2018 at the InterContinental Hotel. With more than 30 sessions, FutureLink Chicago will offer customized tracks for global, diversified and clinical stage pharmaceutical companies, wholesale distributors, pharmacies and hospitals, including APCE continuing education (CE) accreditation courses.

FutureLink Chicago: A Customizable Experience for Life Sciences Companies
The only annual event that gathers commercial, operational, and clinical care leaders from across the pharmaceutical and healthcare delivery industries, FutureLink Chicago is designed to deliver educational sessions to help companies plan for the next stages of the U.S. Drug Supply Chain Security Act (DSCSA), while also providing insight into the future of the digital drug supply chain. Attendees will learn first-hand from industry leaders on serialization data analytics, saleable return verification pilots, product recalls, patient engagement, and receive practical user group training on TraceLink software applications.

Featured Industry Speakers at FutureLink Chicago Include:

  • Cyndi Poetker, Director of Standards and Traceability, Abbott
    General Session: "Business as Usual: Day-to-Day Serialization Management and Analytics"
  • Scott Mooney, Vice President, Distribution Operations Supply Chain Assurance, McKesson Corporation and Joel Warren, Executive Director, Strategic Initiatives, Akorn

    General Panel Session: "DSCSA 2019, 2020 and 2023"

  • Bob Celeste, Founder, Center for Supply Chain Studies

    General Session: "Blockchain and DSCSA: The Real Deal"

  • Mike Mazur, Director, Trade Operation Excellence, Pfizer and Lisa Baird, National Director of Pharmacy Operations, Ernest Health

    General Panel Session: "Pharmaceutical Recalls: Supply Challenges and Opportunities"

  • Bjoern Rosner, Global Serialization Program Lead, Biogen

    General Session: "Leveraging Serialized Product Information Across Your Supply Ecosystem"

  • Sarah Krug, CEO, Health Collaboratory and Cancer 101

    General Session: "Patient Engagement: Delivering the Right Information to the Right Patient at the Right Time"

  • Sarath Ramakrishnan, Director, Life Sciences Advisory Services, KPMG

    General Session: "Verification Router Service (VRS): Standards, Systems and Implementation"

  • Tom Meier, Senior Project Manager, Henry Schein and Trevor McGee, Systems Developer, Value Drug
    Wholesale Distributor Track Session: Preparing Inventory and Distribution Operations for Serialization
  • Andy Meyer, Senior Traceability Analyst, North Carolina Mutual Wholesale Drug

    Wholesale Distributor Track Session: "Piloting Serialization and Saleable Returns"

  • Dominick Pagnotta, CIO, Rochester Drug Cooperative

    Wholesale Distributor Track Session: "Analytics and Managing Serialization Data"

  • Christopher J. Forst, Clinical Pharmacist

    ACPE Continuing Education Course: "Legislative and Regulatory Update for Pharmacy 2018: Issues that Impact You"

  • Marsha Millonig, President and CEO, Catalyst Enterprises

    ACPE Continuing Education Course: "Controlled Substances: Best Practices for Supply Chain Management"

  • Victor Vercammen, Vice President, Supplylogix

    ACPE Continuing Education Course: "Product Recalls: Minimizing Disruption in the Supply Chain"  

"In just a few weeks, industry leaders will converge at FutureLink to discuss how to leverage real-time, collaborative information-sharing, to not only comply with regulations, but also to operate more cost effectively and deliver better patient outcomes," said Shabbir Dahod, president and CEO, TraceLink. "Through the vast reach of TraceLink's network with over 1,000 life sciences customers and more than 270,000 trade partners, FutureLink is the only industry event that truly provides the epicenter for supply chain and IT leaders to explore the limitless opportunities of a fully digital pharmaceutical supply chain with a platform approach."

At the end of the first day of the conference, there will be an evening reception at Chicago's renowned Museum of Science and Industry, where conference attendees will enjoy a night of entertainment and networking with peers, including a tour of the U-505 submarine.

To register for FutureLink Chicago and build your own customized agenda, please visit

About TraceLink

TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.

View original content to download multimedia:

SOURCE TraceLink Inc.

Editor Details

Last Updated: 23-Oct-2018